investigator-sponsored studies

Data from Merck’s Oncology Portfolio Highlight Significant Advances in Cancer Care at ASCO21

Darmstadt, Germany:   New analyses from pivotal BAVENCIO® study reinforce unique clinical benefits across different subgroups in the treatment of advanced…

Read More »